Top

Published in:

01-06-2017 | NON-THEMATIC REVIEW

Radiation-induced inflammatory cascade and its reverberating crosstalks as potential cause of post-radiotherapy second malignancies

Authors: Sonia Gandhi, Sudhir Chandna

Published in: Cancer and Metastasis Reviews | Issue 2/2017

Abstract

The disease-free survival following radiotherapy is often limited by the development of second/secondary cancers. This significant impediment to effective cancer treatment implicated even in the modern-day radiotherapy needs to be countered effectively. Critical analysis reveals that besides achieving effective tumor control, radiotherapy elicits certain cellular and systemic inflammatory events in tumor infiltrate, which remain relatively stable and tend to facilitate “in-field” or “out of field” oncogenesis in due course of time. Acute pro-inflammatory cytokines generated as a result of radiation-induced oxidative insult and DNA damage induce genetic instability that contributes to tumor heterogeneity and plasticity. The reverberating crosstalks between radiation-targeted tumor and its microenvironment in turn initiate inflammatory loops that feedback the immune system to manifest as systemic consequences. An “inflammatory switchover” within the tumor microenvironment is thus induced by cumulative radiation exposure, initiating pro-tumor events that can severely limit the outcome of radiotherapy. Various pro-survival tumorigenic pathways activated as a result regulate radiation-induced hypoxia, ECM remodeling, angiogenesis/vasculogenesis, and immune suppression/evasion within the tumor microenvironment. NF-κB, HIF and STAT are identified as central regulating mediators among others that orchestrate inflammatory switchover from apoptosis-mediated tumor surveillance to radiation-induced carcinogenesis. Radiation-induced interleukins stimulate recruited macrophages and endothelial cells to promote intravasation, which is further aided by release of chemokines favoring extravasation and secondary site lesions. We hence propose that delineating the inflammatory signaling network emanating from irradiation of complex tumor tissue is critical for devising suitable therapeutic strategies to prevent post-radiotherapy second cancers or metastasis.

Available only for authorised users

Travis, L. B., Demark Wahnefried, W., Allan, J. M., Wood, M. E., & Ng, A. K. (2013). Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nature Reviews. Clinical Oncology, 10(5), 289–301. doi:10.1038/nrclinonc.2013.41.PubMedCrossRef

Ringborg, U., Bergqvist, D., Brorsson, B., Cavallin-Stahl, E., Ceberg, J., Einhorn, N., et al. (2003). The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001—summary and conclusions. Acta Oncologica, 42(5–6), 357–365.PubMedCrossRef

Hei, T. K., Zhou, H., Ivanov, V. N., Hong, M., Lieberman, H. B., Brenner, D. J., et al. (2008). Mechanism of radiation-induced bystander effects: a unifying model. The Journal of Pharmacy and Pharmacology, 60(8), 943–950. doi:10.1211/jpp.60.8.0001.PubMedPubMedCentralCrossRef

Berrington de Gonzalez, A., Curtis, R. E., Kry, S. F., Gilbert, E., Lamart, S., Berg, C. D., et al. (2011). Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. The Lancet Oncology, 12(4), 353–360. doi:10.1016/S1470-2045(11)70061-4.PubMedCrossRef

Thompson, D. E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., et al. (1994). Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiation Research, 137(2 Suppl), S17–S67.PubMedCrossRef

Preston, D. L., Kusumi, S., Tomonaga, M., Izumi, S., Ron, E., Kuramoto, A., et al. (1994). Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiation Research, 137(2 Suppl), S68–S97.PubMedCrossRef

Mullenders, L., Atkinson, M., Paretzke, H., Sabatier, L., & Bouffler, S. (2009). Assessing cancer risks of low-dose radiation. Nature Reviews. Cancer, 9(8), 596–604. doi:10.1038/nrc2677.PubMedCrossRef

Robison, L. L., Armstrong, G. T., Boice, J. D., Chow, E. J., Davies, S. M., Donaldson, S. S., et al. (2009). The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. Journal of Clinical Oncology, 27(14), 2308–2318. doi:10.1200/JCO.2009.22.3339.PubMedPubMedCentralCrossRef

Meadows, A. T., Friedman, D. L., Neglia, J. P., Mertens, A. C., Donaldson, S. S., Stovall, M., et al. (2009). Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. Journal of Clinical Oncology, 27(14), 2356–2362. doi:10.1200/JCO.2008.21.1920.PubMedPubMedCentralCrossRef

10.

Friedman, D. L., Whitton, J., Leisenring, W., Mertens, A. C., Hammond, S., Stovall, M., et al. (2010). Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Journal of the National Cancer Institute, 102(14), 1083–1095. doi:10.1093/jnci/djq238.PubMedPubMedCentralCrossRef

11.

Hall, E. J. (2006). Intensity-modulated radiation therapy, protons, and the risk of second cancers. International Journal of Radiation Oncology, Biology, Physics, 65(1), 1–7. doi:10.1016/j.ijrobp.2006.01.027.PubMedCrossRef

12.

Smith, G. (2014). UNSCEAR 2013 Report. Volume I: Report to the General Assembly, Annex A: levels and effects of radiation exposure due to the nuclear accident after the 2011 great east-Japan earthquake and tsunami. Journal of Radiological Protection, 34(3), 725–727. doi:10.1088/0952-4746/34/3/B01.PubMedCrossRef

13.

Mancuso, M., Pasquali, E., Leonardi, S., Tanori, M., Rebessi, S., Di Majo, V., et al. (2008). Oncogenic bystander radiation effects in patched heterozygous mouse cerebellum. Proceedings of the National Academy of Sciences of the United States of America, 105(34), 12445–12450. doi:10.1073/pnas.0804186105.PubMedPubMedCentralCrossRef

14.

Brenner, D. J., Little, J. B., & Sachs, R. K. (2001). The bystander effect in radiation oncogenesis: II. A quantitative model. Radiation Research, 155(3), 402–408.PubMedCrossRef

15.

Prise, K. M., & O'Sullivan, J. M. (2009). Radiation-induced bystander signalling in cancer therapy. Nature Reviews. Cancer, 9(5), 351–360. doi:10.1038/nrc2603.PubMedPubMedCentralCrossRef

16.

Palm, A., & Johansson, K. A. (2007). A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Acta Oncologica, 46(4), 462–473. doi:10.1080/02841860701218626.PubMedCrossRef

17.

Ghosh, S., Kumar, A., Tripathi, R. P., & Chandna, S. (2014). Connexin-43 regulates p38-mediated cell migration and invasion induced selectively in tumour cells by low doses of gamma-radiation in an ERK-1/2-independent manner. Carcinogenesis, 35(2), 383–395. doi:10.1093/carcin/bgt303.PubMedCrossRef

18.

Siva, S., MacManus, M. P., Martin, R. F., & Martin, O. A. (2015). Abscopal effects of radiation therapy: a clinical review for the radiobiologist. Cancer Letters, 356(1), 82–90. doi:10.1016/j.canlet.2013.09.018.PubMedCrossRef

19.

Newhauser, W. D., & Durante, M. (2011). Assessing the risk of second malignancies after modern radiotherapy. Nature Reviews. Cancer, 11(6), 438–448. doi:10.1038/nrc3069.PubMedPubMedCentralCrossRef

20.

Han, E. Y., Paudel, N., Sung, J., Yoon, M., Chung, W. K., & Kim, D. W. (2016). Estimation of the risk of secondary malignancy arising from whole-breast irradiation: comparison of five radiotherapy modalities, including TomoHDA. Oncotarget, 7(16), 22960–22969. doi:10.18632/oncotarget.8392.PubMedPubMedCentralCrossRef

21.

Martin, O. A., Yin, X., Forrester, H. B., Sprung, C. N., & Martin, R. F. (2016). Potential strategies to ameliorate risk of radiotherapy-induced second malignant neoplasms. Seminars in Cancer Biology, 37-38, 65–76. doi:10.1016/j.semcancer.2015.12.003.PubMedCrossRef

22.

Hall, E. J., & Wuu, C. S. (2003). Radiation-induced second cancers: the impact of 3D-CRT and IMRT. International Journal of Radiation Oncology, Biology, Physics, 56(1), 83–88.PubMedCrossRef

23.

Chargari, C., Goodman, K. A., Diallo, I., Guy, J. B., Rancoule, C., Cosset, J. M., et al. (2016). Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models? Cancer Metastasis Reviews, 35(2), 277–288. doi:10.1007/s10555-016-9616-2.PubMedCrossRef

24.

Barcellos-Hoff, M. H., Park, C., & Wright, E. G. (2005). Radiation and the microenvironment—tumorigenesis and therapy. Nature Reviews. Cancer, 5(11), 867–875. doi:10.1038/nrc1735.PubMedCrossRef

25.

Neriishi, K., Nakashima, E., & Delongchamp, R. R. (2001). Persistent subclinical inflammation among A-bomb survivors. International Journal of Radiation Biology, 77(4), 475–482. doi:10.1080/09553000010024911.PubMedCrossRef

26.

Golding, S. E., Rosenberg, E., Neill, S., Dent, P., Povirk, L. F., & Valerie, K. (2007). Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Research, 67(3), 1046–1053. doi:10.1158/0008-5472.CAN-06-2371.PubMedCrossRef

27.

Boucher, M. J., Morisset, J., Vachon, P. H., Reed, J. C., Laine, J., & Rivard, N. (2000). MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. Journal of Cellular Biochemistry, 79(3), 355–369.PubMedCrossRef

28.

Carapancea, M., Cosaceanu, D., Budiu, R., Kwiecinska, A., Tataranu, L., Ciubotaru, V., et al. (2007). Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells. Journal of Neuro-Oncology, 85(3), 245–254. doi:10.1007/s11060-007-9417-0.PubMedCrossRef

29.

Toulany, M., Kehlbach, R., Florczak, U., Sak, A., Wang, S., Chen, J., et al. (2008). Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Molecular Cancer Therapeutics, 7(7), 1772–1781. doi:10.1158/1535-7163.MCT-07-2200.PubMedCrossRef

30.

Lorimore, S. A., & Wright, E. G. (2003). Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. International Journal of Radiation Biology, 79(1), 15–25.PubMedCrossRef

31.

Mukherjee, D., Coates, P. J., Lorimore, S. A., & Wright, E. G. (2012). The in vivo expression of radiation-induced chromosomal instability has an inflammatory mechanism. Radiation Research, 177(1), 18–24.PubMedCrossRef

32.

Leonard, J. M., Ye, H., Wetmore, C., & Karnitz, L. M. (2008). Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability. The Journal of Cell Biology, 183(3), 385–391. doi:10.1083/jcb.200804042.PubMedPubMedCentralCrossRef

33.

Oguma, K., Oshima, H., & Oshima, M. (2010). Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development. Future Oncology, 6(4), 515–526. doi:10.2217/fon.10.13.PubMedCrossRef

34.

Gu, X., Wang, X., Xiao, H., Ma, G., Cui, L., Li, Y., et al. (2015). Silencing of R-Spondin1 increases radiosensitivity of glioma cells. Oncotarget, 6(12), 9756–9765. doi:10.18632/oncotarget.3395.PubMedPubMedCentralCrossRef

35.

Kendziorra, E., Ahlborn, K., Spitzner, M., Rave-Frank, M., Emons, G., Gaedcke, J., et al. (2011). Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis, 32(12), 1824–1831. doi:10.1093/carcin/bgr222.PubMedPubMedCentralCrossRef

36.

Koturbash, I., Rugo, R. E., Hendricks, C. A., Loree, J., Thibault, B., Kutanzi, K., et al. (2006). Irradiation induces DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo. Oncogene, 25(31), 4267–4275. doi:10.1038/sj.onc.1209467.PubMedCrossRef

37.

Wormann, S. M., Song, L., Ai, J., Diakopoulos, K. N., Kurkowski, M. U., Gorgulu, K., et al. (2016). Loss of P53 function activates JAK2-STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient survival. Gastroenterology, 151(1), 180–193 e112. doi:10.1053/j.gastro.2016.03.010.PubMedCrossRef

38.

Zhao, W., & Robbins, M. E. (2009). Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Current Medicinal Chemistry, 16(2), 130–143.PubMedCrossRef

39.

Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., et al. (2001). Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science, 293(5528), 293–297. doi:10.1126/science.1060191.PubMedCrossRef

40.

Chargari, C., Clemenson, C., Martins, I., Perfettini, J. L., & Deutsch, E. (2013). Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Drug Resistance Updates, 16(1–2), 10–21. doi:10.1016/j.drup.2013.01.001.PubMedCrossRef

41.

Miyamoto, Y., Hosotani, R., Doi, R., Wada, M., Ida, J., Tsuji, S., et al. (2001). Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells. Anticancer Research, 21(4A), 2449–2456.PubMed

42.

Lee, E. J., Park, H. J., Lee, I. J., Kim, W. W., Ha, S. J., Suh, Y. G., et al. (2014). Inhibition of IL-17A suppresses enhanced-tumor growth in low dose pre-irradiated tumor beds. PloS One, 9(9), e106423. doi:10.1371/journal.pone.0106423.PubMedPubMedCentralCrossRef

43.

Van der Meeren, A., Monti, P., Lebaron-Jacobs, L., Marquette, C., & Gourmelon, P. (2001). Characterization of the acute inflammatory response after irradiation in mice and its regulation by interleukin 4 (Il4). Radiation Research, 155(6), 858–865.PubMedCrossRef

44.

Rofstad, E. K., Mathiesen, B., Henriksen, K., Kindem, K., & Galappathi, K. (2005). The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Research, 65(6), 2387–2396. doi:10.1158/0008-5472.CAN-04-3039.PubMedCrossRef

45.

Karagiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012). Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Molecular Cancer Research, 10(11), 1403–1418. doi:10.1158/1541-7786.MCR-12-0307.PubMedPubMedCentralCrossRef

46.

Sakurai, A., Doci, C. L., & Gutkind, J. S. (2012). Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Research, 22(1), 23–32. doi:10.1038/cr.2011.198.PubMedCrossRef

47.

Skuli, N., Monferran, S., Delmas, C., Favre, G., Bonnet, J., Toulas, C., et al. (2009). Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma. Cancer Research, 69(8), 3308–3316. doi:10.1158/0008-5472.CAN-08-2158.PubMedCrossRef

48.

Monnier, Y., Farmer, P., Bieler, G., Imaizumi, N., Sengstag, T., Alghisi, G. C., et al. (2008). CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. Cancer Research, 68(18), 7323–7331. doi:10.1158/0008-5472.CAN-08-0841.PubMedCrossRef

49.

Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., et al. (2007). Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine, 13(9), 1050–1059. doi:10.1038/nm1622.PubMedCrossRef

50.

Wang, H., Yang, H., Czura, C. J., Sama, A. E., & Tracey, K. J. (2001). HMGB1 as a late mediator of lethal systemic inflammation. American Journal of Respiratory and Critical Care Medicine, 164(10 Pt 1), 1768–1773. doi:10.1164/ajrccm.164.10.2106117.PubMedCrossRef

51.

Calveley, V. L., Khan, M. A., Yeung, I. W., Vandyk, J., & Hill, R. P. (2005). Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation. International Journal of Radiation Biology, 81(12), 887–899. doi:10.1080/09553000600568002.PubMedCrossRef

52.

Ahmed, K. M., Nantajit, D., Fan, M., Murley, J. S., Grdina, D. J., & Li, J. J. (2009). Coactivation of ATM/ERK/NF-kappaB in the low-dose radiation-induced radioadaptive response in human skin keratinocytes. Free Radical Biology & Medicine, 46(11), 1543–1550. doi:10.1016/j.freeradbiomed.2009.03.012.CrossRef

53.

Kimura, K., & Gelmann, E. P. (2002). Propapoptotic effects of NF-kappaB in LNCaP prostate cancer cells lead to serine protease activation. Cell Death and Differentiation, 9(9), 972–980. doi:10.1038/sj.cdd.4401049.PubMedCrossRef

54.

Veuger, S. J., Hunter, J. E., & Durkacz, B. W. (2009). Ionizing radiation-induced NF-kappaB activation requires PARP-1 function to confer radioresistance. Oncogene, 28(6), 832–842. doi:10.1038/onc.2008.439.PubMedCrossRef

55.

Takeshima, T., Chamoto, K., Wakita, D., Ohkuri, T., Togashi, Y., Shirato, H., et al. (2010). Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Research, 70(7), 2697–2706. doi:10.1158/0008-5472.CAN-09-2982.PubMedCrossRef

56.

Merrick, A., Errington, F., Milward, K., O'Donnell, D., Harrington, K., Bateman, A., et al. (2005). Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming. British Journal of Cancer, 92(8), 1450–1458. doi:10.1038/sj.bjc.6602518.PubMedPubMedCentralCrossRef

57.

Moyer, J. S., Li, J., Wei, S., Teitz-Tennenbaum, S., & Chang, A. E. (2008). Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma. Journal of Immunotherapy, 31(9), 885–895. doi:10.1097/CJI.0b013e3181880f1e.PubMedPubMedCentralCrossRef

58.

Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005). Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. Journal of Immunology, 174(12), 7516–7523.CrossRef

59.

Ahn, G. O., & Brown, J. M. (2008). Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell, 13(3), 193–205. doi:10.1016/j.ccr.2007.11.032.PubMedPubMedCentralCrossRef

60.

Liang, H., Deng, L., Chmura, S., Burnette, B., Liadis, N., Darga, T., et al. (2013). Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. Journal of Immunology, 190(11), 5874–5881. doi:10.4049/jimmunol.1202612.CrossRef

61.

Tsai, C. S., Chen, F. H., Wang, C. C., Huang, H. L., Jung, S. M., Wu, C. J., et al. (2007). Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. International Journal of Radiation Oncology, Biology, Physics, 68(2), 499–507. doi:10.1016/j.ijrobp.2007.01.041.PubMedCrossRef

62.

Coates, P. J., Rundle, J. K., Lorimore, S. A., & Wright, E. G. (2008). Indirect macrophage responses to ionizing radiation: implications for genotype-dependent bystander signaling. Cancer Research, 68(2), 450–456. doi:10.1158/0008-5472.CAN-07-3050.PubMedCrossRef

63.

Chiang, C. S., Fu, S. Y., Wang, S. C., Yu, C. F., Chen, F. H., Lin, C. M., et al. (2012). Irradiation promotes an m2 macrophage phenotype in tumor hypoxia. Frontiers in Oncology, 2, 89. doi:10.3389/fonc.2012.00089.PubMedPubMedCentralCrossRef

64.

Zhang, L., Ye, S. B., Li, Z. L., Ma, G., Chen, S. P., He, J., et al. (2014). Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients. International Journal of Clinical and Experimental Pathology, 7(7), 3887–3897.PubMedPubMedCentral

65.

Gupta, Y., Pasupuleti, V., Du, W., & Welford, S. M. (2016). Macrophage migration inhibitory factor secretion is induced by ionizing radiation and oxidative stress in cancer cells. PloS One, 11(1), e0146482. doi:10.1371/journal.pone.0146482.PubMedPubMedCentralCrossRef

66.

Milas, L., Wike, J., Hunter, N., Volpe, J., & Basic, I. (1987). Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Research, 47(4), 1069–1075.PubMed

67.

Youn, H., Son, B., Kim, W., Jun, S. Y., Lee, J. S., Lee, J. M., et al. (2015). Dissociation of MIF-rpS3 complex and sequential NF-kappaB activation is involved in IR-induced metastatic conversion of NSCLC. Journal of Cellular Biochemistry, 116(11), 2504–2516. doi:10.1002/jcb.25195.PubMedCrossRef

68.

Kuonen, F., Laurent, J., Secondini, C., Lorusso, G., Stehle, J. C., Rausch, T., et al. (2012). Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy. Clinical Cancer Research, 18(16), 4365–4374. doi:10.1158/1078-0432.CCR-11-3028.PubMedCrossRef

69.

Heissig, B., Rafii, S., Akiyama, H., Ohki, Y., Sato, Y., Rafael, T., et al. (2005). Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. The Journal of Experimental Medicine, 202(6), 739–750. doi:10.1084/jem.20050959.PubMedPubMedCentralCrossRef

70.

Stoecklein, V. M., Osuka, A., Ishikawa, S., Lederer, M. R., Wanke-Jellinek, L., & Lederer, J. A. (2015). Radiation exposure induces inflammasome pathway activation in immune cells. Journal of Immunology, 194(3), 1178–1189. doi:10.4049/jimmunol.1303051.CrossRef

71.

Pogany, G. C., & Lewis, K. C. (1985). Enhancement of cathepsin B activity in irradiated mouse testes. Journal of Radiation Research, 26(2), 248–256.PubMedCrossRef

72.

Orlowski, G. M., Colbert, J. D., Sharma, S., Bogyo, M., Robertson, S. A., & Rock, K. L. (2015). Multiple cathepsins promote pro-IL-1beta synthesis and NLRP3-mediated IL-1beta activation. Journal of Immunology, 195(4), 1685–1697. doi:10.4049/jimmunol.1500509.CrossRef

73.

Paquette, B., Therriault, H., & Wagner, J. R. (2013). Role of interleukin-1beta in radiation-enhancement of MDA-MB-231 breast cancer cell invasion. Radiation Research, 180(3), 292–298. doi:10.1667/RR3240.1.PubMedCrossRef

74.

Liu, Y. G., Chen, J. K., Zhang, Z. T., Ma, X. J., Chen, Y. C., Du, X. M., et al. (2017). NLRP3 inflammasome activation mediates radiation-induced pyroptosis in bone marrow-derived macrophages. Cell Death & Disease, 8(2), e2579. doi:10.1038/cddis.2016.460.CrossRef

75.

Vaupel, P., & Multhoff, G. (2016). Adenosine can thwart antitumor immune responses elicited by radiotherapy: therapeutic strategies alleviating protumor ADO activities. Strahlentherapie und Onkologie, 192(5), 279–287. doi:10.1007/s00066-016-0948-1.PubMedCrossRef

76.

Perez-Aso, M., Mediero, A., Low, Y. C., Levine, J., & Cronstein, B. N. (2015). Adenosine A2A receptor plays an important role in radiation-induced dermal injury. The FASEB Journal. doi:10.1096/fj.15-280388.

77.

Ferrante, C. J., Pinhal-Enfield, G., Elson, G., Cronstein, B. N., Hasko, G., Outram, S., et al. (2013). The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling. Inflammation, 36(4), 921–931. doi:10.1007/s10753-013-9621-3.PubMedPubMedCentralCrossRef

78.

Eckle, T., Faigle, M., Grenz, A., Laucher, S., Thompson, L. F., & Eltzschig, H. K. (2008). A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood, 111(4), 2024–2035. doi:10.1182/blood-2007-10-117044.PubMedPubMedCentralCrossRef

79.

Yeom, C. J., Goto, Y., Zhu, Y., Hiraoka, M., & Harada, H. (2012). Microenvironments and cellular characteristics in the micro tumor cords of malignant solid tumors. International Journal of Molecular Sciences, 13(11), 13949–13965. doi:10.3390/ijms131113949.PubMedPubMedCentralCrossRef

80.

Ouyang, Y., Li, H., Bu, J., Li, X., Chen, Z., & Xiao, T. (2016). Hypoxia-inducible factor-1 expression predicts osteosarcoma patients’ survival: a meta-analysis. The International Journal of Biological Markers, 31(3), e229–e234. doi:10.5301/jbm.5000216.PubMedCrossRef

81.

Moeller, B. J., Dreher, M. R., Rabbani, Z. N., Schroeder, T., Cao, Y., Li, C. Y., et al. (2005). Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell, 8(2), 99–110. doi:10.1016/j.ccr.2005.06.016.PubMedCrossRef

82.

Lo, J. F., Yu, C. C., Chiou, S. H., Huang, C. Y., Jan, C. I., Lin, S. C., et al. (2011). The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Research, 71(5), 1912–1923. doi:10.1158/0008-5472.CAN-10-2350.PubMedCrossRef

83.

Lonardo, E., Hermann, P. C., Mueller, M. T., Huber, S., Balic, A., Miranda-Lorenzo, I., et al. (2011). Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell, 9(5), 433–446. doi:10.1016/j.stem.2011.10.001.PubMedCrossRef

84.

Harada, H., Itasaka, S., Kizaka-Kondoh, S., Shibuya, K., Morinibu, A., Shinomiya, K., et al. (2009). The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors. The Journal of Biological Chemistry, 284(8), 5332–5342. doi:10.1074/jbc.M806653200.PubMedCrossRef

85.

Zhu, Y., Zhao, T., Itasaka, S., Zeng, L., Yeom, C. J., Hirota, K., et al. (2013). Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1-S cell cycle transition in radioresistance of perinecrotic tumor cells. Oncogene, 32(16), 2058–2068. doi:10.1038/onc.2012.223.PubMedCrossRef

86.

Liu, Y., Song, X., Wang, X., Wei, L., Liu, X., Yuan, S., et al. (2010). Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells. Journal of Cellular Biochemistry, 111(3), 554–563. doi:10.1002/jcb.22739.PubMedCrossRef

87.

Nanduri, J., Vaddi, D. R., Khan, S. A., Wang, N., Makarenko, V., Semenza, G. L., et al. (2015). HIF-1alpha activation by intermittent hypoxia requires NADPH oxidase stimulation by xanthine oxidase. PloS One, 10(3), e0119762. doi:10.1371/journal.pone.0119762.PubMedPubMedCentralCrossRef

88.

Bussink, J., Kaanders, J. H., Rijken, P. F., Raleigh, J. A., & Van der Kogel, A. J. (2000). Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiation Research, 153(4), 398–404.PubMedCrossRef

89.

Kioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010). Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. The Journal of Clinical Investigation, 120(3), 694–705. doi:10.1172/JCI40283.PubMedPubMedCentralCrossRef

90.

Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004). Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell, 5(5), 429–441.PubMedCrossRef

91.

Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., et al. (2008). NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature, 453(7196), 807–811. doi:10.1038/nature06905.PubMedPubMedCentralCrossRef

92.

Ji, F., Wang, Y., Qiu, L., Li, S., Zhu, J., Liang, Z., et al. (2013). Hypoxia inducible factor 1alpha-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer. International Journal of Oncology, 42(5), 1578–1588. doi:10.3892/ijo.2013.1878.PubMedPubMedCentral

93.

Chang, C. C., Lin, B. R., Chen, S. T., Hsieh, T. H., Li, Y. J., & Kuo, M. Y. (2011). HDAC2 promotes cell migration/invasion abilities through HIF-1alpha stabilization in human oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, 40(7), 567–575. doi:10.1111/j.1600-0714.2011.01009.x.CrossRef

94.

Kim, W. Y., Oh, S. H., Woo, J. K., Hong, W. K., & Lee, H. Y. (2009). Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha. Cancer Research, 69(4), 1624–1632. doi:10.1158/0008-5472.CAN-08-0505.PubMedPubMedCentralCrossRef

95.

Koh, M. Y., Lemos Jr., R., Liu, X., & Powis, G. (2011). The hypoxia-associated factor switches cells from HIF-1alpha- to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Research, 71(11), 4015–4027. doi:10.1158/0008-5472.CAN-10-4142.PubMedPubMedCentralCrossRef

96.

Bertout, J. A., Majmundar, A. J., Gordan, J. D., Lam, J. C., Ditsworth, D., Keith, B., et al. (2009). HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proceedings of the National Academy of Sciences of the United States of America, 106(34), 14391–14396. doi:10.1073/pnas.0907357106.PubMedPubMedCentralCrossRef

97.

Zhao, J., Du, F., Luo, Y., Shen, G., Zheng, F., & Xu, B. (2015). The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors. Cancer Treatment Reviews, 41(7), 623–633. doi:10.1016/j.ctrv.2015.05.004.PubMedCrossRef

98.

Kaliski, A., Maggiorella, L., Cengel, K. A., Mathe, D., Rouffiac, V., Opolon, P., et al. (2005). Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Molecular Cancer Therapeutics, 4(11), 1717–1728. doi:10.1158/1535-7163.MCT-05-0179.PubMedCrossRef

99.

Abdollahi, A., Griggs, D. W., Zieher, H., Roth, A., Lipson, K. E., Saffrich, R., et al. (2005). Inhibition of alpha (v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clinical Cancer Research, 11(17), 6270–6279. doi:10.1158/1078-0432.CCR-04-1223.PubMedCrossRef

100.

Scharpfenecker, M., Kruse, J. J., Sprong, D., Russell, N. S., Ten Dijke, P., & Stewart, F. A. (2009). Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. International Journal of Radiation Oncology, Biology, Physics, 73(2), 506–513. doi:10.1016/j.ijrobp.2008.09.052.PubMedCrossRef

101.

Yahyanejad, S., Theys, J., & Vooijs, M. (2016). Targeting notch to overcome radiation resistance. Oncotarget, 7(7), 7610–7628. doi:10.18632/oncotarget.6714.PubMedCrossRef

102.

Annabi, B., Lee, Y. T., Martel, C., Pilorget, A., Bahary, J. P., & Beliveau, R. (2003). Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (−) epigallocatechin-3-gallate. Cancer Biology & Therapy, 2(6), 642–649.CrossRef

103.

Winkler, F., Kozin, S. V., Tong, R. T., Chae, S. S., Booth, M. F., Garkavtsev, I., et al. (2004). Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell, 6(6), 553–563. doi:10.1016/j.ccr.2004.10.011.PubMed

104.

Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A., Moses, H. L., et al. (2007). Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. The Journal of Clinical Investigation, 117(5), 1305–1313. doi:10.1172/JCI30740.PubMedPubMedCentralCrossRef

105.

Kang, J., Kim, W., Kwon, T., Youn, H., Kim, J. S., & Youn, B. (2016). Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells. Oncotarget, 7(17), 23961–23974. doi:10.18632/oncotarget.8208.PubMedPubMedCentralCrossRef

106.

Guo, Q., Guo, P., Mao, Q., Lan, J., Lin, Y., Jiang, J., et al. (2013). ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways. Medical Oncology, 30(1), 325. doi:10.1007/s12032-012-0325-6.PubMedCrossRef

107.

Segreto, H. R., Ferreira, A. T., Kimura, E. T., Franco, M., Egami, M. I., Silva, M. R., et al. (2002). Amifostine does not prevent activation of TGFbeta1 but induces smad 7 activation in megakaryocytes irradiated in vivo. American Journal of Hematology, 71(3), 143–151. doi:10.1002/ajh.10201.PubMedCrossRef

108.

Imaizumi, N., Monnier, Y., Hegi, M., Mirimanoff, R. O., & Ruegg, C. (2010). Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting. PloS One, 5(6), e11084. doi:10.1371/journal.pone.0011084.PubMedPubMedCentralCrossRef

109.

Tsai, J. H., Makonnen, S., Feldman, M., Sehgal, C. M., Maity, A., & Lee, W. M. (2005). Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer Biology & Therapy, 4(12), 1395–1400.CrossRef

110.

Lerman, O. Z., Greives, M. R., Singh, S. P., Thanik, V. D., Chang, C. C., Seiser, N., et al. (2010). Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and -independent SDF-1 induction. Blood, 116(18), 3669–3676. doi:10.1182/blood-2009-03-213629.PubMedCrossRef

111.

Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006). Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Research, 66(13), 6683–6691. doi:10.1158/0008-5472.CAN-06-0425.PubMedCrossRef

112.

Milas, L., Kishi, K., Hunter, N., Mason, K., Masferrer, J. L., & Tofilon, P. J. (1999). Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. Journal of the National Cancer Institute, 91(17), 1501–1504.PubMedCrossRef

113.

Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011). Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood, 118(20), 5498–5505. doi:10.1182/blood-2011-07-365825.PubMedPubMedCentralCrossRef

114.

Brocard, E., Oizel, K., Lalier, L., Pecqueur, C., Paris, F., Vallette, F. M., et al. (2015). Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling. Oncotarget, 6(9), 6840–6849. doi:10.18632/oncotarget.3160.PubMedPubMedCentralCrossRef

115.

Barshishat-Kupper, M., Mungunsukh, O., Tipton, A. J., McCart, E. A., Panganiban, R. A., Davis, T. A., et al. (2011). Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation. Experimental Hematology, 39(3), 293–304. doi:10.1016/j.exphem.2010.12.002.PubMedCrossRef

116.

Wu, X., Huang, W., Luo, G., & Alain, L. A. (2013). Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling. Molecular and Cellular Biochemistry, 384(1–2), 155–162. doi:10.1007/s11010-013-1793-5.PubMedPubMedCentralCrossRef

117.

Gerber, S. A., Sedlacek, A. L., Cron, K. R., Murphy, S. P., Frelinger, J. G., & Lord, E. M. (2013). IFN-gamma mediates the antitumor effects of radiation therapy in a murine colon tumor. The American Journal of Pathology, 182(6), 2345–2354. doi:10.1016/j.ajpath.2013.02.041.PubMedPubMedCentralCrossRef

118.

Lau, J., Ilkhanizadeh, S., Wang, S., Miroshnikova, Y. A., Salvatierra, N. A., Wong, R. A., et al. (2015). STAT3 blockade inhibits radiation-induced malignant progression in glioma. Cancer Research, 75(20), 4302–4311. doi:10.1158/0008-5472.CAN-14-3331.PubMedPubMedCentralCrossRef

119.

Maleki Vareki, S., Rytelewski, M., Figueredo, R., Chen, D., Ferguson, P. J., Vincent, M., et al. (2014). Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin. Oncotarget, 5(9), 2778–2791. doi:10.18632/oncotarget.1916.PubMedCrossRef

120.

Pei, J., Park, I. H., Ryu, H. H., Li, S. Y., Li, C. H., Lim, S. H., et al. (2015). Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model. Radiation Oncology, 10, 164. doi:10.1186/s13014-015-0475-8.PubMedPubMedCentralCrossRef

121.

Chan, L. L., Czerniak, B. A., & Ginsberg, L. E. (2000). Radiation-induced osteosarcoma after bilateral childhood retinoblastoma. AJR. American Journal of Roentgenology, 174(5), 1288. doi:10.2214/ajr.174.5.1741288.PubMedCrossRef

122.

Tsukamoto, H., Shibata, K., Kajiyama, H., Terauchi, M., Nawa, A., & Kikkawa, F. (2007). Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecologic Oncology, 107(3), 500–504. doi:10.1016/j.ygyno.2007.08.058.PubMedCrossRef

123.

Eke, I., Deuse, Y., Hehlgans, S., Gurtner, K., Krause, M., Baumann, M., et al. (2012). Beta(1)integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. The Journal of Clinical Investigation, 122(4), 1529–1540. doi:10.1172/JCI61350.PubMedPubMedCentralCrossRef

124.

Jia, S., Jia, Y., Weeks, H. P., Ruge, F., Feng, X., Ma, R., et al. (2014). Down-regulation of WAVE2, WASP family verprolin-homologous protein 2, in gastric cancer indicates lymph node metastasis and cell migration. Anticancer Research, 34(5), 2185–2194.PubMed

125.

Trog, D., Yeghiazaryan, K., Fountoulakis, M., Friedlein, A., Moenkemann, H., Haertel, N., et al. (2006). Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. European Journal of Pharmacology, 542(1–3), 8–15. doi:10.1016/j.ejphar.2006.05.026.PubMedCrossRef

126.

Qian, L. W., Mizumoto, K., Urashima, T., Nagai, E., Maehara, N., Sato, N., et al. (2002). Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clinical Cancer Research, 8(4), 1223–1227.PubMed

127.

Speake, W. J., Dean, R. A., Kumar, A., Morris, T. M., Scholefield, J. H., & Watson, S. A. (2005). Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion. European Journal of Surgical Oncology, 31(8), 869–874. doi:10.1016/j.ejso.2005.05.016.PubMedCrossRef

128.

Gogineni, V. R., Kargiotis, O., Klopfenstein, J. D., Gujrati, M., Dinh, D. H., & Rao, J. S. (2009). RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells. International Journal of Oncology, 34(1), 209–218.PubMedPubMedCentral

129.

Dancea, H. C., Shareef, M. M., & Ahmed, M. M. (2009). Role of radiation-induced TGF-beta signaling in cancer therapy. Molecular and Cellular Pharmacology, 1(1), 44–56.PubMedPubMedCentralCrossRef

130.

Flechsig, P., Dadrich, M., Bickelhaupt, S., Jenne, J., Hauser, K., Timke, C., et al. (2012). LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-beta and BMP-associated proinflammatory and proangiogenic signals. Clinical Cancer Research, 18(13), 3616–3627. doi:10.1158/1078-0432.CCR-11-2855.PubMedCrossRef

131.

Murdoch, C., Giannoudis, A., & Lewis, C. E. (2004). Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood, 104(8), 2224–2234. doi:10.1182/blood-2004-03-1109.PubMedCrossRef

132.

Kwak, S. Y., Yang, J. S., Kim, B. Y., Bae, I. H., & Han, Y. H. (2014). Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B rhoGAP. Biochimica et Biophysica Acta, 1843(3), 508–516. doi:10.1016/j.bbamcr.2013.11.021.PubMedCrossRef

133.

Vilalta, M., Rafat, M., & Graves, E. E. (2016). Effects of radiation on metastasis and tumor cell migration. Cellular and Molecular Life Sciences, 73(16), 2999–3007. doi:10.1007/s00018-016-2210-5.PubMedPubMedCentralCrossRef

134.

Chen, F. H., Fu, S. Y., Yang, Y. C., Wang, C. C., Chiang, C. S., & Hong, J. H. (2013). Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway. International Journal of Radiation Oncology, Biology, Physics, 86(4), 777–784. doi:10.1016/j.ijrobp.2013.02.036.PubMedCrossRef

135.

Condeelis, J., & Segall, J. E. (2003). Intravital imaging of cell movement in tumours. Nature Reviews. Cancer, 3(12), 921–930. doi:10.1038/nrc1231.PubMedCrossRef

136.

Ding, N. H., Li, J. J., & Sun, L. Q. (2013). Molecular mechanisms and treatment of radiation-induced lung fibrosis. Current Drug Targets, 14(11), 1347–1356.PubMedPubMedCentralCrossRef

137.

Chen, M. F., Hsieh, C. C., Chen, W. C., & Lai, C. H. (2012). Role of interleukin-6 in the radiation response of liver tumors. International Journal of Radiation Oncology, Biology, Physics, 84(5), e621–e630. doi:10.1016/j.ijrobp.2012.07.2360.PubMedCrossRef

138.

Zhou, Y., Xia, L., He, Z. S., Ouyang, W., Z, H., & Xie, C. H. (2010). Modulation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in RAW264.7 cells by irradiation. Molecular Medicine Reports, 3(5), 809–813. doi:10.3892/mmr.2010.326.PubMed

139.

Qian, L. W., Mizumoto, K., Inadome, N., Nagai, E., Sato, N., Matsumoto, K., et al. (2003). Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. International Journal of Cancer, 104(5), 542–549. doi:10.1002/ijc.10997.PubMedCrossRef

140.

Verheij, M., Dewit, L., & van Mourik, J. A. (1997). Radiation-induced von Willebrand factor release. Blood, 90(5), 2109–2110.PubMed

141.

Odell Jr., T. T., Jackson, C. W., & Friday, T. J. (1971). Effects of radiation on the thrombocytopoietic system of mice. Radiation Research, 48(1), 107–115.PubMedCrossRef

142.

Niswander, L. M., Fegan, K. H., Kingsley, P. D., McGrath, K. E., & Palis, J. (2014). SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury. Blood, 124(2), 277–286. doi:10.1182/blood-2014-01-547638.PubMedPubMedCentralCrossRef

143.

Kennedy, A. R., Maity, A., & Sanzari, J. K. (2016). A review of radiation-induced coagulopathy and new findings to support potential prevention strategies and treatments. Radiation Research, 186(2), 121–140. doi:10.1667/RR14406.1.PubMedPubMedCentralCrossRef

144.

Jackowski, S., Janusch, M., Fiedler, E., Marsch, W. C., Ulbrich, E. J., Gaisbauer, G., et al. (2007). Radiogenic lymphangiogenesis in the skin. The American Journal of Pathology, 171(1), 338–348. doi:10.2353/ajpath.2007.060589.PubMedPubMedCentralCrossRef

145.

Grebhardt, S., Veltkamp, C., Strobel, P., & Mayer, D. (2012). Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer. International Journal of Cancer, 131(12), 2785–2794. doi:10.1002/ijc.27591.PubMedCrossRef

146.

Ahn, G. O., Tseng, D., Liao, C. H., Dorie, M. J., Czechowicz, A., & Brown, J. M. (2010). Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proceedings of the National Academy of Sciences of the United States of America, 107(18), 8363–8368. doi:10.1073/pnas.0911378107.PubMedPubMedCentralCrossRef

147.

Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., et al. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell, 15(1), 35–44. doi:10.1016/j.ccr.2008.11.012.PubMedPubMedCentralCrossRef

148.

Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820–827. doi:10.1038/nature04186.PubMedPubMedCentralCrossRef

149.

Kunisada, M., Yogianti, F., Sakumi, K., Ono, R., Nakabeppu, Y., & Nishigori, C. (2011). Increased expression of versican in the inflammatory response to UVB- and reactive oxygen species-induced skin tumorigenesis. The American Journal of Pathology, 179(6), 3056–3065. doi:10.1016/j.ajpath.2011.08.042.PubMedPubMedCentralCrossRef

150.

Sheng, W., Wang, G., La Pierre, D. P., Wen, J., Deng, Z., Wong, C. K., et al. (2006). Versican mediates mesenchymal-epithelial transition. Molecular Biology of the Cell, 17(4), 2009–2020. doi:10.1091/mbc.E05-10-0951.PubMedPubMedCentralCrossRef

151.

Cummings, R. J., Gerber, S. A., Judge, J. L., Ryan, J. L., Pentland, A. P., & Lord, E. M. (2012). Exposure to ionizing radiation induces the migration of cutaneous dendritic cells by a CCR7-dependent mechanism. Journal of Immunology, 189(9), 4247–4257. doi:10.4049/jimmunol.1201371.CrossRef

152.

Vilalta, M., Rafat, M., Giaccia, A. J., & Graves, E. E. (2014). Recruitment of circulating breast cancer cells is stimulated by radiotherapy. Cell Reports, 8(2), 402–409. doi:10.1016/j.celrep.2014.06.011.PubMedPubMedCentralCrossRef

153.

Hallahan, D., Kuchibhotla, J., & Wyble, C. (1996). Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. Cancer Research, 56(22), 5150–5155.PubMed

154.

Zhang, H., Wong, C. C., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., et al. (2012). HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene, 31(14), 1757–1770. doi:10.1038/onc.2011.365.PubMedCrossRef

155.

Liang, H., Deng, L., Burnette, B., Weichselbaum, R. R., & Fu, Y. X. (2013). Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cells. Oncoimmunology, 2(9), e25668. doi:10.4161/onci.25668.PubMedPubMedCentralCrossRef

156.

Hahnel, A., Wichmann, H., Kappler, M., Kotzsch, M., Vordermark, D., Taubert, H., et al. (2010). Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells. Radiation Oncology, 5, 82. doi:10.1186/1748-717X-5-82.PubMedPubMedCentralCrossRef

Title: Radiation-induced inflammatory cascade and its reverberating crosstalks as potential cause of post-radiotherapy second malignancies
Authors: Sonia Gandhi
Sudhir Chandna
Publication date: 01-06-2017
Publisher: Springer US
Published in: Cancer and Metastasis Reviews / Issue 2/2017
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-017-9669-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

The influence of platelet membranes on tumour cell behaviour

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention

The potential role of platelets in the consensus molecular subtypes of colorectal cancer

Platelets, circulating tumor cells, and the circulome

Platelets and cancer angiogenesis nexus

Platelet RNA signatures for the detection of cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer